Plasma biomarkers of brain atrophy in Alzheimer's disease - Test2 - elhamkhani - TriplyDB

Plasma biomarkers of brain atrophy in Alzheimer's disease

Plasma biomarkers of brain atrophy in Alzheimer's disease

http://www.wikidata.org/entity/Q28741028

about

Blood-Based Proteomic Biomarkers of Alzheimer's Disease Pathology Biomarkers in Alzheimer's disease analysis by mass spectrometry-based proteomics Imago Mundi, Imago AD, Imago ADNI Functional impact of oxidative posttranslational modifications on fibrinogen and fibrin clots.A novel Aβ-fibrinogen interaction inhibitor rescues altered thrombosis and cognitive decline in Alzheimer's disease mice TheHiveDB image data management and analysis framework.Altered levels of blood proteins in Alzheimer's disease longitudinal study: Results from Australian Imaging Biomarkers Lifestyle Study of Ageing cohort.Exploring the potential of the platelet membrane proteome as a source of peripheral biomarkers for Alzheimer's disease.Cognitive Variability during Middle-Age: Possible Association with Neurodegeneration and Cognitive Reserve The future of blood-based biomarkers for Alzheimer's disease.Developing novel blood-based biomarkers for Alzheimer's disease Plasma based markers of [11C] PiB-PET brain amyloid burden.Plasma proteins predict conversion to dementia from prodromal disease Circulating miRNA biomarkers for Alzheimer's disease Upregulation of glycolytic enzymes, mitochondrial dysfunction and increased cytotoxicity in glial cells treated with Alzheimer's disease plasma.Plasma protein profiling for potential biomarkers in the early diagnosis of Alzheimer's disease.Plasma proteomics for the identification of Alzheimer disease.Blood protein predictors of brain amyloid for enrichment in clinical trials?Hyperhomocysteinemia exacerbates Alzheimer's disease pathology by way of the β-amyloid fibrinogen interaction Effects of cerebrospinal fluid proteins on brain atrophy rates in cognitively healthy older adults.The transcriptomic response of mixed neuron-glial cell cultures to 1,25-dihydroxyvitamin d3 includes genes limiting the progression of neurodegenerative diseases.Fibrinogen and altered hemostasis in Alzheimer's disease Plasma biomarkers for Alzheimer's disease: much needed but tough to find.Use of proteomic methods in the analysis of human body fluids in Alzheimer research.New insight into neurodegeneration: the role of proteomics.Complement Biomarkers as Predictors of Disease Progression in Alzheimer's Disease.The Correlation between Inflammatory Biomarkers and Polygenic Risk Score in Alzheimer's Disease.Reduction of Cerebral and Corpus Callosum Volumes in Childhood-Onset Systemic Lupus Erythematosus: A Volumetric Magnetic Resonance Imaging Analysis.Fibrin deposited in the Alzheimer's disease brain promotes neuronal degeneration Soluble interleukin-6 receptor levels and risk of dementia: one more signpost on a long road ahead.Alpha-2 macroglobulin in Alzheimer's disease: a marker of neuronal injury through the RCAN1 pathway.Complement in the pathogenesis of Alzheimer's disease.Blood will out: vascular contributions to Alzheimer's disease.Blood-Based Biomarker Candidates of Cerebral Amyloid Using PiB PET in Non-Demented Elderly.A Decade of Blood Biomarkers for Alzheimer's Disease Research: An Evolving Field, Improving Study Designs, and the Challenge of Replication.Roles of serum fibrinogen α chain-derived peptides in Alzheimer's disease.Classification and prediction of clinical diagnosis of Alzheimer's disease based on MRI and plasma measures of α-/γ-tocotrienols and γ-tocopherol."Immune Gate" of Psychopathology-The Role of Gut Derived Immune Activation in Major Psychiatric Disorders.Detection of Alzheimer's Disease

P2860

Q26774743-3C83824B-826E-4B0A-AEE6-1221BC23B584 Q27024518-158DC652-C30B-4401-810C-958F56954214 Q28650395-F4D94C1D-902F-41D4-A967-FDC8CFD987EF Q30352067-0C5F415E-2369-4D8D-8E5C-6E73A6243708 Q30579707-9787B725-B07E-4E11-B3FB-20B37FEF1978 Q30734877-8884E4B3-F606-4A55-BAC1-27C2CF6073CA Q33652456-1BA8290C-C325-4126-A0F8-07BF1127E468 Q33745920-B73DD441-ECB3-420E-B9FB-5B721601D04E Q33780670-C0ED8544-905B-46D8-90B8-FB4A92400191 Q34026317-62953BEA-0F22-4D6B-9654-DA38D7A5716B Q34394080-2E5FCC37-DA6E-4F6F-9477-7609AA1F8C8C Q34427001-1451217A-5C66-4C18-BD44-8092FA76580E Q34556953-88217C80-88AC-485C-8995-B14E820C2E57 Q34904013-C4787968-65AE-419E-AE4E-0B317B18507B Q35191570-2594B4F5-CA7F-48B0-88E7-8F63E60036D4 Q36256076-EAA0F0EC-3808-4C07-89D4-0C2A0696A2ED Q36767124-07AD08CD-A287-4E29-9CBD-1E1E46FC1FFD Q36926754-B992C977-38CB-4AE9-B3A8-A79B6DC2CB21 Q37104293-7EDBF45F-65D1-4D8E-A979-96F0C7282505 Q37395886-84BAD442-668A-41CB-B4C3-D45A5CC0FC64 Q37656221-20B1B81B-0234-4F67-80D3-F565DB5849C9 Q38032520-FDFDC770-4C4A-4670-9B65-E886EC0C6E40 Q38037157-81EA399D-1C65-4D84-8CDF-84C753905013 Q38060574-20191966-04AB-480E-BDDF-75EAE8D387F1 Q38170010-32658D31-B17A-4242-BB6F-0C3AC53397DF Q39447009-3109CD45-5C19-4308-83E5-B7CCD7FA4076 Q40426419-88F413A4-C458-4EDC-82B1-97CBAA9114AB Q40845375-BF4E6822-C706-433A-B04B-BAC76C9110D6 Q41916686-D237B62B-B56B-4A05-9D6A-CC92D15F3742 Q43244936-453F87B6-1DC0-4A6B-975E-6C9B70EB5D90 Q47201004-C5E84DB1-B97F-4320-B33A-768793EF952C Q47709505-13B5CE32-85D3-430D-9F45-A4475B9B1F49 Q49498166-1F67CA8B-9744-40B4-8E47-FD1FD922761B Q50221800-5786C46A-EFCD-4FCF-A8DC-CE33CA8BE19F Q51760901-2E6AD2AE-ECF3-4513-89CD-67EE952327E7 Q53345656-E3FD631F-7B63-4F52-A7DF-41E5D2DF619D Q53447021-A27023D5-86FB-40BB-AFF6-0149AD2D7F90 Q55110638-994E26C7-786A-4854-AFBA-6634E00A4417 Q58706105-63B25E2F-F44D-4903-B018-62048ADE5754

P2860

Plasma biomarkers of brain atrophy in Alzheimer's disease

http://www.wikidata.org/entity/Q28741028

description

2011 nî lūn-bûn

@nan

2011 թուականին հրատարակուած գիտական յօդուած

@hyw

2011 թվականին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Plasma biomarkers of brain atrophy in Alzheimer's disease

@ast

Plasma biomarkers of brain atrophy in Alzheimer's disease

@en

Plasma biomarkers of brain atrophy in Alzheimer's disease

@nl

type

label

Plasma biomarkers of brain atrophy in Alzheimer's disease

@ast

Plasma biomarkers of brain atrophy in Alzheimer's disease

@en

Plasma biomarkers of brain atrophy in Alzheimer's disease

@nl

prefLabel

Plasma biomarkers of brain atrophy in Alzheimer's disease

@ast

Plasma biomarkers of brain atrophy in Alzheimer's disease

@en

Plasma biomarkers of brain atrophy in Alzheimer's disease

@nl

P1433

Q28741028-659E6334-7CC4-445E-BDDD-FB64FABA1295

P1476

Q28741028-BB05CABC-6D12-42AB-B0E4-1FA6071877F0

P2093

Q28741028-0106D40C-E3DF-4D95-84C3-3A120016EC90

Q28741028-0A54DFDC-4E2F-4ED1-8C5A-EBA8DEF611F9

Q28741028-54120EA8-6750-474C-8762-61157F68618D

Q28741028-B3B5E507-7C89-4062-95C5-33F0ABFCAB20

Q28741028-E11D7CD7-C74A-4ACE-AF12-60734EF8C957

P2860

Q28741028-0A49E790-9076-4CDC-AA60-7F06F3FFD774

Q28741028-0ACCEDF8-E14E-4BA4-A8C4-DE5462B5F092

Q28741028-0CC7D4FE-5868-42D3-823B-FD79256B2616

Q28741028-0F06B3C6-3FD1-4020-81DD-241084CAD63C

Q28741028-153598E7-BF6F-4782-B607-24543E17B131

Q28741028-2D0D57FA-AECA-44CC-B778-639C3DA77E49

Q28741028-314D0FAA-95BB-47FD-9C27-FFC9AD6A7352

Q28741028-37E4EA53-6E4C-4777-9C77-F39007ADE9F2

Q28741028-37ECE7B9-6232-4303-8E59-E05E4184BF2A

Q28741028-41C61E10-A419-4585-98EF-654890E8E7E4

P304

Q28741028-E26F7C9A-0722-4926-8BB3-112BC82FA77D

P31

Q28741028-C202B712-808E-4472-ABAF-C43E1164C4BC

P356

Q28741028-37F92B07-FD29-4380-B5B9-8CD0D8699B8E

P407

Q28741028-14F8881E-5700-4664-8F2D-A7FC3FACF153

P433

Q28741028-51A971AE-DDB9-4217-BD25-47482E3DF07B

P478

Q28741028-F69D0DEC-DCFE-4D4A-8F99-084259FD26CD

P50

Q28741028-096D7747-15A6-4C8D-ACC2-36E9D94B51E0

Q28741028-0BB6722A-EC39-4B67-B48D-494689C3C4C0

Q28741028-1566CF71-F3FC-4529-8091-7E1458AA8814

Q28741028-3994267A-7557-486A-A371-D8FFCD4344E0

Q28741028-400D6C42-7E0A-47A9-8D5A-4D2EA6B309B0

Q28741028-6EA9C591-95CD-432C-BF33-D1BDCFA9B3FA

Q28741028-712D3E35-4F1B-4544-B4AD-7531D01554D5

Q28741028-92B21573-A117-4988-B5C3-7C10DA390BC3

Q28741028-ABF11398-B500-423F-A1D0-7B45279B223C

Q28741028-BD9EDA37-325E-4334-8895-BA0C200B887C

P577

Q28741028-F46D9C3F-324C-4946-9032-6FF2816F9500

P5875

Q28741028-0A6EEA93-C330-4FBB-9BE0-2A562B2D7606

P698

Q28741028-49C746DC-E859-4656-AE9F-3C103B3315BC

P921

Q28741028-3DDE9B50-A460-448E-8B5D-D84714717893

Q28741028-9FFEF17F-0121-44BB-A0A7-3C77772B88C2

Q28741028-C9B1B50E-60A6-4830-A4CC-84358BA28905

P932

Q28741028-29B076D6-070B-43DA-B05E-51284E3F054B

P356

JOURNAL.PONE.0028527

P1433

P1476

Plasma biomarkers of brain atrophy in Alzheimer's disease

@en

P2093

Abdul Hye

http://www.w3.org/2001/XMLSchema#string

Andrew Simmons

http://www.w3.org/2001/XMLSchema#string

Christian Spenger

http://www.w3.org/2001/XMLSchema#string

Mirsada Causevic

http://www.w3.org/2001/XMLSchema#string

Yi Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods.

Multiplexed immunoassay panel identifies novel CSF biomarkers for Alzheimer's disease diagnosis and prognosis

Disease-modifying therapies for Alzheimer disease: challenges to early intervention.

Biomarkers of cerebrovascular disease in dementia.

Automatic "pipeline" analysis of 3-D MRI data for clinical trials: application to multiple sclerosis.

Novel panel of cerebrospinal fluid biomarkers for the prediction of progression to Alzheimer dementia in patients with mild cognitive impairment.

Proteome-based plasma biomarkers for Alzheimer's disease.

Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease.

Circulating complement proteins in patients with sepsis or systemic inflammatory response syndrome.

Yin and Yang: complement activation and regulation in Alzheimer's disease.

P304

e28527

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0028527

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Simon Lovestone

Iwona Kłoszewska

Hilkka Soininen

Lars-Olof Wahlund

Patrizia Mecocci

Richard Killick

Magda N. Tsolaki

P577

2011-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51970144

http://www.w3.org/2001/XMLSchema#string

P698

22205954

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

3244409

http://www.w3.org/2001/XMLSchema#string